My Onc. showed me a paper published very recently; it's title is "Sequencing Regorafenib Before Cetuximab Leads to Improved Survival in mCRC". Its result is very interesting.
The paper's main point is that if a patient is treated with Regorafenib first and then with Cetuximab, the overall survival will be improved by about 50%, compared to the conventional way: first Cetuximab and then Regorafenib.
The paper can be found by clicking the following link:
http://www.targetedonc.com/news/sequenc ... al-in-mcrc